Chuck Royce's CLB Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 206,716 shares of Core Laboratories Inc. (CLB) worth $3.31 M, representing 0.03% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 25 quarters.
Based on 13F filings, Chuck Royce has maintained a strategic position in CLB, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2022, adding 738,763 shares. Largest reduction occurred in Q3 2025, reducing 331,918 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Core Laboratories (CLB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Core Laboratories (CLB) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -233,726 | Reduce 53.07% | 206,716 | $16.03 |
| Q3 2025 | -331,918 | Reduce 42.97% | 440,442 | $12.36 |
| Q2 2025 | -198,827 | Reduce 20.47% | 772,360 | $11.52 |
| Q1 2025 | +2,059 | Add 0.21% | 971,187 | $14.99 |
| Q4 2024 | -51,993 | Reduce 5.09% | 969,128 | $17.31 |
| Q3 2024 | +84,022 | Add 8.97% | 1.02 M | $18.53 |
| Q2 2024 | -178,194 | Reduce 15.98% | 937,099 | $20.29 |
| Q1 2024 | +201,019 | Add 21.99% | 1.12 M | $17.08 |
| Q4 2023 | +225,006 | Add 32.64% | 914,274 | $17.66 |
| Q3 2023 | +72,476 | Add 11.75% | 689,268 | $24.01 |
| Q2 2023 | -36,877 | Reduce 5.64% | 616,792 | $23.25 |
| Q1 2023 | -85,094 | Reduce 11.52% | 653,669 | $22.05 |
| Q4 2022 | +738,763 | New Buy | 738,763 | $20.27 |
| Q4 2019 | -77,500 | Sold Out | 0 | $0.00 |
| Q3 2019 | +2,500 | Add 3.33% | 77,500 | $46.62 |
| Q1 2019 | +75,000 | New Buy | 75,000 | $68.93 |
| Q3 2015 | -5,000 | Sold Out | 0 | $0.00 |
| Q2 2015 | -3,200 | Reduce 39.02% | 5,000 | $114.00 |
| Q4 2014 | +8,200 | New Buy | 8,200 | $120.37 |
| Q1 2014 | -100 | Sold Out | 0 | $0.00 |
| Q4 2013 | -17,600 | Reduce 99.44% | 100 | $190.00 |
| Q2 2013 | +17,700 | Add 0.00% | 17,700 | $151.64 |
Chuck Royce's Core Laboratories Investment FAQs
Chuck Royce first purchased Core Laboratories Inc. (CLB) in Q2 2013, acquiring 17,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Core Laboratories Inc. (CLB) for 25 quarters since Q2 2013.
Chuck Royce's largest addition to Core Laboratories Inc. (CLB) was in Q4 2022, adding 738,763 shares worth $14.97 M.
According to the latest 13F filing for Q4 2025, Chuck Royce's firm, Royce & Associates Lp, owns 206,716 shares of Core Laboratories Inc. (CLB), valued at approximately $3.31 M.
As of the Q4 2025 filing, Core Laboratories Inc. (CLB) represents approximately 0.03% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Core Laboratories Inc. (CLB) was 1,115,293 shares, as reported at the end of Q1 2024.